-
1
-
-
82455167129
-
Comparison of the lower confidence limit to the fixed-percentage method for assessing airway obstruction in routine clinical practice
-
Aggarwal AN, Gupta D, Agarwal R, Jindal SK. Comparison of the lower confidence limit to the fixed-percentage method for assessing airway obstruction in routine clinical practice. Respir Care. 2011; 56(11):1778–1784.
-
(2011)
Respir Care
, vol.56
, Issue.11
, pp. 1778-1784
-
-
Aggarwal, A.N.1
Gupta, D.2
Agarwal, R.3
Jindal, S.K.4
-
2
-
-
84920920455
-
-
Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS). A joint project of GINA and GOLD
-
Global Initiative for Asthma. Diagnosis of Diseases of Chronic Airflow Limitation: Asthma, COPD and Asthma-COPD Overlap Syndrome (ACOS). A joint project of GINA and GOLD. 2015.
-
(2015)
Diagnosis of Diseases of Chronic Airflow Limitation
-
-
-
3
-
-
84864863776
-
Consensus document on the overlap phenotype COPD-asthma in COPD
-
Soler-Cataluna JJ, Cosio B, Izquierdo JL, et al. Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol. 2012;48(9):331–337.
-
(2012)
Arch Bronconeumol
, vol.48
, Issue.9
, pp. 331-337
-
-
Soler-Cataluna, J.J.1
Cosio, B.2
Izquierdo, J.L.3
-
5
-
-
84941176876
-
The asthma-COPD overlap syndrome: Towards a revised taxonomy of chronic airways diseases?
-
Bateman ED, Reddel HK, van Zyl-Smit RN, Agusti A. The asthma-COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases? Lancet Respir Med. 2015;3(9):719–728.
-
(2015)
Lancet Respir Med
, vol.3
, Issue.9
, pp. 719-728
-
-
Bateman, E.D.1
Reddel, H.K.2
van Zyl-Smit, R.N.3
Agusti, A.4
-
6
-
-
84937467900
-
Prevalence of asthma-COPD overlap syndrome among primary care asthmatics with a smoking history: A cross-sectional study
-
Kiljander T, Helin T, Venho K, Jaakkola A, Lehtimaki L. Prevalence of asthma-COPD overlap syndrome among primary care asthmatics with a smoking history: a cross-sectional study. NPJ Prim Care Respir Med. 2015;25:15047.
-
(2015)
NPJ Prim Care Respir Med
, vol.25
-
-
Kiljander, T.1
Helin, T.2
Venho, K.3
Jaakkola, A.4
Lehtimaki, L.5
-
7
-
-
85047695734
-
Clinical phenotypes of COPD: Identification, definition and implications for guidelines
-
Miravitlles M, Calle M, Soler-Cataluna JJ. Clinical phenotypes of COPD: identification, definition and implications for guidelines. Arch Bronconeumol. 2012;48(3):86–98.
-
(2012)
Arch Bronconeumol
, vol.48
, Issue.3
, pp. 86-98
-
-
Miravitlles, M.1
Calle, M.2
Soler-Cataluna, J.J.3
-
8
-
-
78649874704
-
Individually-tailored treatment of chronic obstructive pulmonary disease: A proposed change
-
Miravitlles M. Individually-tailored treatment of chronic obstructive pulmonary disease: a proposed change. Arch Bronconeumol. 2009;45(Suppl 5):27–34.
-
(2009)
Arch Bronconeumol
, vol.45
, pp. 27-34
-
-
Miravitlles, M.1
-
9
-
-
84986223146
-
What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion
-
Sin DD, Miravitlles M, Mannino DM, et al. What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion. Eur Respir J. 2016;48(3):664–673.
-
(2016)
Eur Respir J
, vol.48
, Issue.3
, pp. 664-673
-
-
Sin, D.D.1
Miravitlles, M.2
Mannino, D.M.3
-
10
-
-
42949152368
-
Bronchodilator responsiveness in patients with COPD
-
Tashkin DP, Celli B, Decramer M, et al. Bronchodilator responsiveness in patients with COPD. Eur Respir J. 2008;31(4):742–750.
-
(2008)
Eur Respir J
, vol.31
, Issue.4
, pp. 742-750
-
-
Tashkin, D.P.1
Celli, B.2
Decramer, M.3
-
11
-
-
84969872387
-
Blood eosinophil count to predict bronchial eosinophilic inflammation in COPD
-
Schleich F, Corhay JL, Louis R. Blood eosinophil count to predict bronchial eosinophilic inflammation in COPD. Eur Respir J. 2016; 47(5):1562–1564.
-
(2016)
Eur Respir J
, vol.47
, Issue.5
, pp. 1562-1564
-
-
Schleich, F.1
Corhay, J.L.2
Louis, R.3
-
12
-
-
0037425745
-
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: A randomised controlled trial
-
Calverley P, Pauwels R, Vestbo J, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2003;361(9356):449–456.
-
(2003)
Lancet
, vol.361
, Issue.9356
, pp. 449-456
-
-
Calverley, P.1
Pauwels, R.2
Vestbo, J.3
-
13
-
-
33847172367
-
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
-
Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356(8):775–789.
-
(2007)
N Engl J Med
, vol.356
, Issue.8
, pp. 775-789
-
-
Calverley, P.M.1
Anderson, J.A.2
Celli, B.3
-
14
-
-
0347473812
-
Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease
-
Calverley PM, Boonsawat W, Cseke Z, Zhong N, Peterson S, Olsson H. Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. Eur Respir J. 2003;22(6):912–919.
-
(2003)
Eur Respir J
, vol.22
, Issue.6
, pp. 912-919
-
-
Calverley, P.M.1
Boonsawat, W.2
Cseke, Z.3
Zhong, N.4
Peterson, S.5
Olsson, H.6
-
15
-
-
1842370350
-
Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group
-
Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med. 1997;337(20):1405–1411.
-
(1997)
N Engl J Med
, vol.337
, Issue.20
, pp. 1405-1411
-
-
Pauwels, R.A.1
Lofdahl, C.G.2
Postma, D.S.3
-
16
-
-
33747761653
-
Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: A randomised controlled, double-blind study
-
Rabe KF, Atienza T, Magyar P, Larsson P, Jorup C, Lalloo UG. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet. 2006;368(9537):744–753.
-
(2006)
Lancet
, vol.368
, Issue.9537
, pp. 744-753
-
-
Rabe, K.F.1
Atienza, T.2
Magyar, P.3
Larsson, P.4
Jorup, C.5
Lalloo, U.G.6
-
17
-
-
0037246566
-
Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease
-
Szafranski W, Cukier A, Ramirez A, et al. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J. 2003;21(1):74–81.
-
(2003)
Eur Respir J
, vol.21
, Issue.1
, pp. 74-81
-
-
Szafranski, W.1
Cukier, A.2
Ramirez, A.3
-
18
-
-
53749102775
-
A 4-year trial of tiotropium in chronic obstructive pulmonary disease
-
Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359(15): 1543–1554.
-
(2008)
N Engl J Med
, vol.359
, Issue.15
, pp. 1543-1554
-
-
Tashkin, D.P.1
Celli, B.2
Senn, S.3
-
19
-
-
70349854706
-
Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease
-
Welte T, Miravitlles M, Hernandez P, et al. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180(8):741–750.
-
(2009)
Am J Respir Crit Care Med
, vol.180
, Issue.8
, pp. 741-750
-
-
Welte, T.1
Miravitlles, M.2
Hernandez, P.3
-
20
-
-
84973882932
-
Indacaterol-glycopyrronium versus salmeterol-fluticasone for COPD
-
Wedzicha JA, Banerji D, Chapman KR, et al. Indacaterol-glycopyrronium versus salmeterol-fluticasone for COPD. N Engl J Med. 2016; 374(23):2222–2234.
-
(2016)
N Engl J Med
, vol.374
, Issue.23
, pp. 2222-2234
-
-
Wedzicha, J.A.1
Banerji, D.2
Chapman, K.R.3
-
21
-
-
84949895524
-
Asthma-COPD overlap syndrome (ACOS): A diagnostic challenge
-
Tho NV, Park HY, Nakano Y. Asthma-COPD overlap syndrome (ACOS): a diagnostic challenge. Respirology. 2016;21(3):410–418.
-
(2016)
Respirology
, vol.21
, Issue.3
, pp. 410-418
-
-
Tho, N.V.1
Park, H.Y.2
Nakano, Y.3
-
22
-
-
0001859044
-
A technique for the measurement of attitudes
-
Likert R. A technique for the measurement of attitudes. Arch Psychol. 1932(140):1–55.
-
(1932)
Arch Psychol
, vol.140
, pp. 1-55
-
-
Likert, R.1
-
23
-
-
84924798508
-
Diagnosis and pharma-cotherapy of stable chronic obstructive pulmonary disease: The Finnish guidelines
-
Kankaanranta H, Harju T, Kilpelainen M, et al. Diagnosis and pharma-cotherapy of stable chronic obstructive pulmonary disease: the Finnish guidelines. Basic Clin Pharmacol Toxicol. 2015;116(4):291–307.
-
(2015)
Basic Clin Pharmacol Toxicol
, vol.116
, Issue.4
, pp. 291-307
-
-
Kankaanranta, H.1
Harju, T.2
Kilpelainen, M.3
-
24
-
-
84874682687
-
A new approach to grading and treating COPD based on clinical phenotypes: Summary of the Spanish COPD guidelines (GesEPOC)
-
Miravitlles M, Soler-Cataluna JJ, Calle M, et al. A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC). Prim Care Respir J. 2013;22(1):117–121.
-
(2013)
Prim Care Respir J
, vol.22
, Issue.1
, pp. 117-121
-
-
Miravitlles, M.1
Soler-Cataluna, J.J.2
Calle, M.3
-
25
-
-
84555196141
-
Guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 3rd edition
-
Japanese
-
Nagai A. [Guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 3rd edition]. Nihon Rinsho. 2011;69(10): 1729–1734. Japanese.
-
(2011)
Nihon Rinsho
, vol.69
, Issue.10
, pp. 1729-1734
-
-
Nagai, A.1
-
26
-
-
36049036539
-
Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease – 2007 update
-
O’Donnell DE, Aaron S, Bourbeau J, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease – 2007 update. Can Respir J. 2007;14(Suppl B):5B–32B.
-
(2007)
Can Respir J
, vol.14
, pp. 5-32
-
-
O’Donnell, D.E.1
Aaron, S.2
Bourbeau, J.3
-
27
-
-
84879346537
-
Chronic obstructive pulmonary disease: Official diagnosis and treatment guidelines of the Czech Pneu-mological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care
-
Koblizek V, Chlumsky J, Zindr V, et al. Chronic obstructive pulmonary disease: official diagnosis and treatment guidelines of the Czech Pneu-mological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013;157(2):189–201.
-
(2013)
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
, vol.157
, Issue.2
, pp. 189-201
-
-
Koblizek, V.1
Chlumsky, J.2
Zindr, V.3
-
28
-
-
84884813960
-
High hospital burden in overlap syndrome of asthma and COPD
-
Andersen H, Lampela P, Nevanlinna A, Saynajakangas O, Keistinen T. High hospital burden in overlap syndrome of asthma and COPD. Clin Respir J. 2013;7(4):342–346.
-
(2013)
Clin Respir J
, vol.7
, Issue.4
, pp. 342-346
-
-
Andersen, H.1
Lampela, P.2
Nevanlinna, A.3
Saynajakangas, O.4
Keistinen, T.5
-
29
-
-
84916203542
-
Asthma-chronic obstructive pulmonary disease overlap syndrome in Poland. Findings of an epidemiological study
-
Brzostek D, Kokot M. Asthma-chronic obstructive pulmonary disease overlap syndrome in Poland. Findings of an epidemiological study. Postepy Dermatol Alergol. 2014;31(6):372–379.
-
(2014)
Postepy Dermatol Alergol
, vol.31
, Issue.6
, pp. 372-379
-
-
Brzostek, D.1
Kokot, M.2
-
30
-
-
84942297055
-
Asthma and chronic obstructive pulmonary disease overlap syndrome: Doubled costs compared with patients with asthma alone
-
Gerhardsson de Verdier M, Andersson M, Kern DM, Zhou S, Tunceli O. Asthma and chronic obstructive pulmonary disease overlap syndrome: doubled costs compared with patients with asthma alone. Value Health. 2015;18(6):759–766.
-
(2015)
Value Health
, vol.18
, Issue.6
, pp. 759-766
-
-
Gerhardsson de Verdier, M.1
Andersson, M.2
Kern, D.M.3
Zhou, S.4
Tunceli, O.5
-
31
-
-
80053346631
-
The clinical features of the overlap between COPD and asthma
-
Hardin M, Silverman EK, Barr RG, et al. The clinical features of the overlap between COPD and asthma. Respir Res. 2011;12:127.
-
(2011)
Respir Res
, vol.12
, pp. 127
-
-
Hardin, M.1
Silverman, E.K.2
Barr, R.G.3
-
32
-
-
84893689291
-
Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma
-
Menezes AM, Montes de Oca M, Perez-Padilla R, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest. 2014;145(2):297–304.
-
(2014)
Chest
, vol.145
, Issue.2
, pp. 297-304
-
-
Menezes, A.M.1
-
33
-
-
84893317803
-
Longitudinal changes in clinical outcomes in older patients with asthma, COPD and asthma-COPD overlap syndrome
-
Fu JJ, Gibson PG, Simpson JL, McDonald VM. Longitudinal changes in clinical outcomes in older patients with asthma, COPD and asthma-COPD overlap syndrome. Respiration. 2014;87(1):63–74.
-
(2014)
Respiration
, vol.87
, Issue.1
, pp. 63-74
-
-
Fu, J.J.1
Gibson, P.G.2
Simpson, J.L.3
McDonald, V.M.4
-
34
-
-
84903473961
-
Systemic inflammation in older adults with asthma-COPD overlap syndrome
-
Fu JJ, McDonald VM, Gibson PG, Simpson JL. Systemic inflammation in older adults with asthma-COPD overlap syndrome. Allergy Asthma Immunol Res. 2014;6(4):316–324.
-
(2014)
Allergy Asthma Immunol Res
, vol.6
, Issue.4
, pp. 316-324
-
-
Fu, J.J.1
McDonald, V.M.2
Gibson, P.G.3
Simpson, J.L.4
-
35
-
-
84929415616
-
Causes of death in patients with asthma and asthma-chronic obstructive pulmonary disease overlap syndrome
-
Harada T, Yamasaki A, Fukushima T, et al. Causes of death in patients with asthma and asthma-chronic obstructive pulmonary disease overlap syndrome. Int J Chron Obstruct Pulmon Dis. 2015;10:595–602.
-
(2015)
Int J Chron Obstruct Pulmon Dis
, vol.10
, pp. 595-602
-
-
Harada, T.1
Yamasaki, A.2
Fukushima, T.3
-
36
-
-
84960393560
-
Asthma and chronic obstructive pulmonary disease overlap syndrome (ACOS): Structured literature review and physician insights
-
Ding B, Enstone A. Asthma and chronic obstructive pulmonary disease overlap syndrome (ACOS): structured literature review and physician insights. Expert Rev Respir Med. 2016;10(3):363–371.
-
(2016)
Expert Rev Respir Med
, vol.10
, Issue.3
, pp. 363-371
-
-
Ding, B.1
Enstone, A.2
-
37
-
-
84883055167
-
Quality and reproducibility of spirometry in COPD patients in a randomized trial (UPLIFT(R))
-
Janssens W, Liu Y, Liu D, et al. Quality and reproducibility of spirometry in COPD patients in a randomized trial (UPLIFT(R)). Respir Med. 2013;107(9):1409–1416.
-
(2013)
Respir Med
, vol.107
, Issue.9
, pp. 1409-1416
-
-
Janssens, W.1
Liu, Y.2
Liu, D.3
-
38
-
-
84952705854
-
Prevalence of blood eosinophilia in hospitalized patients with acute exacerbation of COPD
-
Hasegawa K, Camargo CA Jr. Prevalence of blood eosinophilia in hospitalized patients with acute exacerbation of COPD. Respirology. 2016;21(4):761–764.
-
(2016)
Respirology
, vol.21
, Issue.4
, pp. 761-764
-
-
Hasegawa, K.1
Camargo, C.A.2
-
39
-
-
84961644450
-
Diagnostic performance of the measurement of nitric oxide in exhaled air in the diagnosis of COPD phenotypes
-
Alcazar-Navarrete B, Romero-Palacios PJ, Ruiz-Sancho A, Ruiz-Rodriguez O. Diagnostic performance of the measurement of nitric oxide in exhaled air in the diagnosis of COPD phenotypes. Nitric Oxide. 2016;54:67–72.
-
(2016)
Nitric Oxide
, vol.54
, pp. 67-72
-
-
Alcazar-Navarrete, B.1
Romero-Palacios, P.J.2
Ruiz-Sancho, A.3
Ruiz-Rodriguez, O.4
-
40
-
-
84989173776
-
Importance of fractional exhaled nitric oxide in the differentiation of asthma-COPD overlap syndrome, asthma, and COPD
-
Chen FJ, Huang XY, Liu YL, Lin GP, Xie CM. Importance of fractional exhaled nitric oxide in the differentiation of asthma-COPD overlap syndrome, asthma, and COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:2385–2390.
-
(2016)
Int J Chron Obstruct Pulmon Dis
, vol.11
, pp. 2385-2390
-
-
Chen, F.J.1
Huang, X.Y.2
Liu, Y.L.3
Lin, G.P.4
Xie, C.M.5
-
41
-
-
84944045833
-
Biomarker-based detection of asthma-COPD overlap syndrome in COPD populations
-
Tamada T, Sugiura H, Takahashi T, et al. Biomarker-based detection of asthma-COPD overlap syndrome in COPD populations. Int J Chron Obstruct Pulmon Dis. 2015;10:2169–2176.
-
(2015)
Int J Chron Obstruct Pulmon Dis
, vol.10
, pp. 2169-2176
-
-
Tamada, T.1
Sugiura, H.2
Takahashi, T.3
-
42
-
-
84962781232
-
Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: A prospective population-based analysis
-
Lange P, Colak Y, Ingebrigtsen TS, Vestbo J, Marott JL. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis. Lancet Respir Med. 2016;4(6):454–462.
-
(2016)
Lancet Respir Med
, vol.4
, Issue.6
, pp. 454-462
-
-
Lange, P.1
Colak, Y.2
Ingebrigtsen, T.S.3
Vestbo, J.4
Marott, J.L.5
-
43
-
-
84942474807
-
The asthma-COPD overlap syndrome
-
Postma DS, Rabe KF. The asthma-COPD overlap syndrome. N Engl J Med. 2015;373(13):1241–1249.
-
(2015)
N Engl J Med
, vol.373
, Issue.13
, pp. 1241-1249
-
-
Postma, D.S.1
Rabe, K.F.2
-
44
-
-
84937721581
-
A reevaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease
-
D’Urzo A, Donohue JF, Kardos P, Miravitlles M, Price D. A reevaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease. Expert Opin Pharmacother. 2015;16(12):1845–1860.
-
(2015)
Expert Opin Pharmacother
, vol.16
, Issue.12
, pp. 1845-1860
-
-
D’Urzo, A.1
Donohue, J.F.2
Kardos, P.3
Miravitlles, M.4
Price, D.5
-
45
-
-
84968750659
-
The pharmacological treatment of chronic obstructive pulmonary disease
-
Gillissen A, Haidl P, Khlhaufl M, Kroegel K, Voshaar T, Gessner C. The pharmacological treatment of chronic obstructive pulmonary disease. Dtsch Arztebl Int. 2016;113(18):311–316.
-
(2016)
Dtsch Arztebl Int
, vol.113
, Issue.18
, pp. 311-316
-
-
Gillissen, A.1
Haidl, P.2
Khlhaufl, M.3
Kroegel, K.4
Voshaar, T.5
Gessner, C.6
-
46
-
-
2442552129
-
Impact of preventing exacerbations on deterioration of health status in COPD
-
Spencer S, Calverley PM, Burge PS, Jones PW. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J. 2004;23(5):698–702.
-
(2004)
Eur Respir J
, vol.23
, Issue.5
, pp. 698-702
-
-
Spencer, S.1
Calverley, P.M.2
Burge, P.S.3
Jones, P.W.4
-
47
-
-
85012258919
-
-
Accessed September 15, 2016
-
Global Initiative for Chronic Obstructive Lung Disease. GOLD Reports. Available from: http://goldcopd.org/gold-reports/. Accessed September 15, 2016.
-
GOLD Reports
-
-
-
48
-
-
84944880515
-
The inevitable drift to triple therapy in COPD: An analysis of prescribing pathways in the UK
-
Brusselle G, Price D, Gruffydd-Jones K, et al. The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK. Int J Chron Obstruct Pulmon Dis. 2015;10:2207–2217.
-
(2015)
Int J Chron Obstruct Pulmon Dis
, vol.10
, pp. 2207-2217
-
-
Brusselle, G.1
Price, D.2
Gruffydd-Jones, K.3
-
49
-
-
81155152484
-
Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD
-
Liesker JJ, Bathoorn E, Postma DS, Vonk JM, Timens W, Kerstjens HA. Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD. Respir Med. 2011;105(12):1853–1860.
-
(2011)
Respir Med
, vol.105
, Issue.12
, pp. 1853-1860
-
-
Liesker, J.J.1
Bathoorn, E.2
Postma, D.S.3
Vonk, J.M.4
Timens, W.5
Kerstjens, H.A.6
-
50
-
-
84964388893
-
Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: A post-hoc analysis of the WISDOM trial
-
Watz H, Tetzlaff K, Wouters EF, et al. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial. Lancet Respir Med. 2016;4(5):390–398.
-
(2016)
Lancet Respir Med
, vol.4
, Issue.5
, pp. 390-398
-
-
Watz, H.1
Tetzlaff, K.2
Wouters, E.F.3
|